Articles by George Koroneos, Online Content & News Editor - Pharmaceutical Executive


Articles by George Koroneos, Online Content & News Editor

New Bill to Curb Pharma ED Ads

May 13, 2009

Two Democratic Congressman have brewed up new legislation to target pharma erectile dysfunction ads rather than going after advertisements with sexually suggestive material in general. Industry experts don't think they have a chance, but the bill could still be a pain for fans of Viva Viagra.

Amylin Drops 200 Sales Reps

May 7, 2009

As it readies submission for a once-weekly diabetes injectable, Amylin announces that it will trim 35 percent of its sales force and put focus on specialty physicians.

Rx Scripts Spike in Wake of Swine Flu

May 7, 2009

New prescriptions for antiviral treatments get huge boost due to H1N1 epidemic. Numbers exceed those seen during this year's influenza season, and the numbers are climbing.

Bio Companies Low on Venture Capital Cash

May 6, 2009

As the economy continues to retract, fewer biotech companies are finding the funding they need to survive, driving more firms to sell or close shop.

Bank on IT

May 1, 2009

Tough economic tmes call for a bold approach to evolving information technology solutions.

Pharma Steps Up to Help With Swine Flu

Apr 29, 2009

As the US government weighs its options on whether to commission a vaccine for the new H1N1 strain of influenza, pharma companies gear up for a possible epidemic.

Ortho-McNeil Launches Facebook Site for Adult ADHD

Apr 29, 2009

Ortho-McNeil is reaching out to the adult ADHD segment through the popular social networking site. The plan is to grow followers through education and unbranded information. Pharm Exec takes a look at the new site.

Pfizer and Glaxo Join Forces in HIV Venture

Apr 22, 2009

The two pharma giants announced plans to form a new specialty company focused on HIV drug development. The new, independent firm will have a total of 11 drugs on the market, with another six on the horizon, securing its place as a powerhouse in the HIV market.

US Pharma Market To Decline in 2009

Apr 22, 2009

IMS has revised its 2009, forecast and the outlook isn't pretty for the United States, which looks to drop 1 to 2 percent in the coming year.


Click here